Avoro Capital Advisors LLC

Q4 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
12/31/2024
Date filed
2/14/2025
Form type
13F-HR
Num holdings
39
Total value ($000)
$7,069,981
Net value change ($000)
+211,830 (3.1%)
New positions
7
Sold out positions
3
Turnover %
4.8%
Sector allocation + QoQ delta (equities-only)
Prev filing: 11/14/2024 Next filing: 5/15/2025 SEC filing

Snapshot: Change Analysis

Compared to Q3 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MDGL 195,495 45.4%
BPMC 103,356 NEW
ARGX 90,309 13.5%
ALKERMES PLC 70,462 NEW
APLS 69,567 21.7%
VERA 46,763 24.5%
QURE 38,411 NEW
ARWR 36,711 21.3%
89bio, Inc. 32,062 NEW
Intra-Cellular Therapies, Inc. 31,567 14.1%
Top Reduces (Value $000, Stocks/ETFs)
RNAM -97,669 -30.9%
KRYS -65,492 -13.7%
UTHR -50,539 -4.9%
KURA -49,603 -71.7%
BMRN -47,122 -32.9%
SNDX -44,776 -59.8%
ASND -42,353 -5.7%
PCVX -38,081 -28.4%
FOLD -29,200 -11.8%
DYN -23,348 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type